Currently accepted at: JMIR Formative Research
Date Submitted: Jan 14, 2026
Open Peer Review Period: Jan 14, 2026 - Mar 2, 2026
Date Accepted: Mar 24, 2026
(closed for review but you can still tweet)
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/91438
The final accepted version (not copyedited yet) is in this tab.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A digital inclusion intervention to improve access to a digital health intervention among digitally excluded adults: a mixed methods pilot study
ABSTRACT
Background:
The NHS 10 Year Health Plan emphasises an increasing shift toward digital healthcare delivery. However, there is limited research on how best to support, engage, and include individuals who are digitally excluded. As services become more digitally driven, there is need for evidence-based interventions that effectively address digital inclusion and ensure equitable access to care.
Objective:
This study aimed to evaluate the feasibility and acceptability of providing digital literacy training alongside a digital health intervention (Ex-Tab), compared with usual care. The study used Kidney Beam (a digital health intervention designed to promote physical activity and improve quality of life in people living with chronic kidney disease (CKD)) as an exemplar digital health intervention (DHI).
Methods:
This mixed-methods, single-site pilot randomised controlled trial (RCT) recruited 40 adults with CKD who were digitally excluded, defined as lacking access to a Wi-Fi–enabled digital device or scoring <7 on the Vanderbilt University Medical Centre digital health care literacy screening tool (DHLS) were included. Participants were randomised 1:1 to the Kidney Beam Ex-Tab digital inclusion intervention or to Kidney Beam alone. Participants in the intervention group received a Wi-Fi–enabled iPad with the Kidney Beam DHI pre-installed, along with training on device use and support to access the 12-week Kidney Beam DHI (twice-weekly live exercise and education sessions). The control group received sign-up instructions for Kidney Beam only. Feasibility outcomes, measured using a priori progression criteria, included screening, recruitment, retention, adherence, safety, and acceptability. Secondary outcomes were Kidney Disease Quality of Life questionnaire, Chalder Fatigue questionnaire and Patient Health Questionnaire-4 (PHQ4). Assessments were conducted at baseline and at 12 weeks. Acceptability and user experience were explored through semi-structured interviews (n=25) at 12 weeks (both groups).
Results:
Between September 2023 and September 2024, 169 individuals were screened and 40 enrolled (median age 66.5 years; 50% male, median DHLS 4), with 21 randomized to Ex-Tab and 19 to control. Thirty-five participants (88%) completed the 12-week follow-up (Ex-Tab n=18; control n=17). All feasibility criteria for recruitment, retention, adherence, and safety were met. The interviews found that the tablet-loan and training component was valuable and acceptable, noting that it enhanced engagement and motivation with the exercises. Providing loaned devices was especially welcomed for overcoming access barriers, particularly among those who could not afford their own.
Conclusions:
Providing Wi-Fi–enabled devices and digital literacy training through the Ex-Tab intervention was feasible and acceptable for people with lower levels of digital literacy. All pre-specified feasibility criteria were met, supporting progression to a future definitive multicentre trial or implementation study. Findings offer insight into the design of digital inclusion strategies that may be transferable to other long-term health conditions. Clinical Trial: The sub-study was approved by the Bromley NHS Research Ethics Committee (Ref: 21/LO/0243) and Health Research Authority, and was pre-registered on ClinicalTrials.gov (NCT04872933).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.